Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|September 23, 2021
IFNβ Is a Potent Adjuvant for Cancer Vaccination StrategiesKatherine M Audsley, Teagan Wagner, Clara Ta, et al.
Oncoimmunology|October 6, 2018
Combination immune checkpoint blockade as an effective therapy for mesotheliomaVanessa S Fear, Caitlin Tilsed, Jonathan Chee, et al.
Scientific Reports|July 29, 2022
Systemic long-term metabolic effects of acute non-severe paediatric burn injurySofina Begum, Blair Z Johnson, Aude-Claire Morillon, et al.
Frontiers in Immunology|August 15, 2020
Pediatric Burn Survivors Have Long-Term Immune Dysfunction With Diminished Vaccine ResponseBlair Z Johnson, Sonia McAlister, Helen M McGuire, et al.
Frontiers in Immunology|November 9, 2020
Corrigendum: Pediatric Burn Survivors Have Long-Term Immune Dysfunction With Diminished Vaccine ResponseBlair Z Johnson, Sonia McAlister, Helen M McGuire, et al.
Scientific Data|May 3, 2024
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapyWee Loong Chin, Rachael M Zemek, Caitlin M Tilsed, et al.
Nature Communications|August 19, 2022
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in miceRachael M Zemek, Wee Loong Chin, Vanessa S Fear, et al.
Frontiers in Immunology|December 2, 2020
Tumor Infiltrating Effector Memory Antigen-Specific CD8+ T Cells Predict Response to Immune Checkpoint TherapyNicola Principe, Joel Kidman, Siting Goh, et al.
Pageof 6